03:19 AM EDT, 06/14/2024 (MT Newswires) -- Susanna Gatti High, Chief Operating Officer, on June 12, 2024, sold 40,000 shares in Dyne Therapeutics ( DYN ) for $1,334,201. Following the Form 4 filing with the SEC, High has control over a total of 148,792 shares of the company, with 148,792 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1818794/000095017024073289/xslF345X03/ownership.xml